127 related articles for article (PubMed ID: 12604567)
1. Enhanced in vitro activity of dihydrofolate reductase and dihydropteroase synthase inhibitors in combination against Nocardia spp.
Thielking DM; Destefano MS; Cynamon MH; Yeo AE
Antimicrob Agents Chemother; 2003 Mar; 47(3):1174. PubMed ID: 12604567
[No Abstract] [Full Text] [Related]
2. New Mycobacterium avium antifolate shows synergistic effect when used in combination with dihydropteroate synthase inhibitors.
Suling WJ; Seitz LE; Reynolds RC; Barrow WW
Antimicrob Agents Chemother; 2005 Nov; 49(11):4801-3. PubMed ID: 16251337
[TBL] [Abstract][Full Text] [Related]
3. Use of bacterial surrogates as a tool to explore antimalarial drug interaction: Synergism between inhibitors of malarial dihydrofolate reductase and dihydropteroate synthase.
Talawanich Y; Kamchonwongpaisan S; Sirawaraporn W; Yuthavong Y
Acta Trop; 2015 Sep; 149():64-9. PubMed ID: 25997881
[TBL] [Abstract][Full Text] [Related]
4. Resistance to trimethoprim-sulfamethoxazole and modifications in genes coding for dihydrofolate reductase and dihydropteroate synthase in European Streptococcus pneumoniae isolates.
Schmitz FJ; Perdikouli M; Beeck A; Verhoef J; Fluit AC;
J Antimicrob Chemother; 2001 Dec; 48(6):935-6. PubMed ID: 11733486
[No Abstract] [Full Text] [Related]
5. New antifolate 4,4'-diaminodiphenyl sulfone substituted 2,4-diamino-5-benzylpyrimidines. Proof of their dual mode of action and autosynergism.
Wiese M; Schmalz D; Seydel JK
Arch Pharm (Weinheim); 1996 Mar; 329(3):161-8. PubMed ID: 9005816
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activities of dihydrofolate reductase inhibitors, used singly or in combination with dapsone, against Mycobacterium ulcerans.
Dhople AM
J Antimicrob Chemother; 2001 Jan; 47(1):93-6. PubMed ID: 11152437
[TBL] [Abstract][Full Text] [Related]
7. In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum.
Ommeh S; Nduati E; Mberu E; Kokwaro G; Marsh K; Rosowsky A; Nzila A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3711-4. PubMed ID: 15388424
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways.
Mehta H; Weng J; Prater A; Elworth RAL; Han X; Shamoo Y
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686152
[No Abstract] [Full Text] [Related]
9. Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors.
Capasso C; Supuran CT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):379-87. PubMed ID: 23627736
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of JPC 2067 alone and in combination with sulfamethoxazole against nocardia species.
Mookherjee S; Shoen C; Cynamon M
Antimicrob Agents Chemother; 2012 Feb; 56(2):1133-4. PubMed ID: 22106219
[TBL] [Abstract][Full Text] [Related]
11. A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors.
Fernley RT; Iliades P; Macreadie I
Anal Biochem; 2007 Jan; 360(2):227-34. PubMed ID: 17134675
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs.
Winstanley PA; Mberu EK; Szwandt IS; Breckenridge AM; Watkins WM
Antimicrob Agents Chemother; 1995 Apr; 39(4):948-52. PubMed ID: 7786001
[TBL] [Abstract][Full Text] [Related]
13. 2,4-diaminopteridine-based compounds as precursors for de novo synthesis of antifolates: a novel class of antimalarials.
Nduati E; Hunt S; Kamau EM; Nzila A
Antimicrob Agents Chemother; 2005 Sep; 49(9):3652-7. PubMed ID: 16127035
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of atovaquone, sulphamethoxazole and dapsone alone and combined with inhibitors of dihydrofolate reductase and macrolides against Pneumocystis carinii.
Cirioni O; Giacometti A; Scalise G
J Antimicrob Chemother; 1997 Jan; 39(1):45-51. PubMed ID: 9044027
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity to antifolates and genetic analysis of Plasmodium vivax isolates from Thailand.
Rungsihirunrat K; Na-Bangchang K; Hawkins VN; Mungthin M; Sibley CH
Am J Trop Med Hyg; 2007 Jun; 76(6):1057-65. PubMed ID: 17556611
[TBL] [Abstract][Full Text] [Related]
16. Dihydrofolate reductase inhibitors as antibacterial agents.
Hawser S; Lociuro S; Islam K
Biochem Pharmacol; 2006 Mar; 71(7):941-8. PubMed ID: 16359642
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of Nocardia to trimethoprim and sulphonamides in vitro.
Black WA; McNellis DA
J Clin Pathol; 1970 Jul; 23(5):423-6. PubMed ID: 5476868
[TBL] [Abstract][Full Text] [Related]
18. Synergy of trimethoprim-sulfamethoxazole.
Bushby SR
Can Med Assoc J; 1975 Jun; 112(13 Spec No):63-6. PubMed ID: 1093654
[No Abstract] [Full Text] [Related]
19. Inhibitors of de novo folate enzymes in Plasmodium falciparum.
Nzila A
Drug Discov Today; 2006 Oct; 11(19-20):939-44. PubMed ID: 16997145
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
Ma L; Borio L; Masur H; Kovacs JA
J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
